Support and resources for providers, patients, and caregivers

Novoeight® has a variety of support and resources to help you and your patient make the most of treatment. We've got just what you need to help him with your recommended Novoeight® treatment plan.

Dylan with hemophilia A holding the Novoeight® logo.


Dylan, 24 years old,
 lives with hemophilia A


 



 

Novoeight® resources for physicians, nurses and other HCPs

Resources for physicians, nurses, and other health care providers

Novoeight® has resources to help you initiate treatment, counsel your patients, and help them have a successful treatment experience.


 



 

Novo Nordisk support for patients and caregivers

Support for patients and caregivers

Novo Nordisk offers comprehensive support for patients and caregivers.


 



 

Additional hemophilia A information resources

Additional resources

Connect patients and caregivers to other sources for hemophilia information.


 



 

Team Novo8

Introduce your patients to Team Novo8™

Members of the community living with with hemophilia A and treating with Novoeight® share their stories. Learn how they are giving back to the hemophilia community.


 



 

How to Order Novoeight®

Click here for a list of vendors who distribute Novoeight®.

Authorized distributor


 



 

Contact a Novoeight Hemophilia Therapy Sales Manager

Talk with us

Connect with a local Novo Nordisk Representative to learn more about the support available for Novoeight®.


 



 

Community partnerships

Novo Nordisk partners with leading organizations such as the National Hemophilia Foundation and the World Federation of Hemophilia to help families affected by hemophilia.

Psychosocial support

Novo Nordisk sponsored the HERO (Hemophilia Experiences, Results, and Opportunities) study to learn more about the psychosocial challenges of living with hemophilia.


 



 

Selected Important Safety Information

Do not use in patients who have had life-threatening hypersensitivity reactions, including anaphylaxis, to Novoeight® or its components, including hamster proteins.

Anaphylaxis and severe hypersensitivity reactions are possible. Patients may develop hypersensitivity to hamster proteins, which are present in trace amounts in the product. Should symptoms occur, discontinue Novoeight® and administer appropriate treatment.

Indications and Usage

Novoeight® (Antihemophilic Factor [Recombinant]) is indicated for use in adults and children with hemophilia A for control and prevention of bleeding, perioperative management, and routine prophylaxis to prevent or reduce the frequency of bleeding episodes.

Novoeight® is not indicated for the treatment of von Willebrand disease.
 

Important Safety Information

Do not use in patients who have had life-threatening hypersensitivity reactions, including anaphylaxis, to Novoeight® or its components, including hamster proteins.

Anaphylaxis and severe hypersensitivity reactions are possible. Patients may develop hypersensitivity to hamster proteins, which are present in trace amounts in the product. Should symptoms occur, discontinue Novoeight® and administer appropriate treatment.

Development of activity-neutralizing antibodies (inhibitors) may occur.  If expected plasma factor VIII activity levels are not attained, or if bleeding is not controlled with an appropriate dose, perform an assay that measures factor VIII inhibitor concentration.

The most frequently reported adverse reactions (≥0.5%) were injection site reactions, increased hepatic enzymes, and pyrexia.


Please click here for Novoeight® Prescribing Information.